Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ethan, den Boer"'
Publikováno v:
Therapeutic Drug Monitoring, 36(6), 819-823. Lippincott Williams and Wilkins
Therapeutic Drug Monitoring, 36(6), 819-823. Lippincott Williams & Wilkins
Den Boer, E, Koch, B C, Huisman, R & De Jonge, R 2014, ' Using fluorescence polarization immunoassay for determination of erythrocyte methotrexate polyglutamates, a quick and easy test? ', Therapeutic Drug Monitoring, vol. 36, no. 6, pp. 819-823 . https://doi.org/10.1097/FTD.0000000000000085
Therapeutic Drug Monitoring, 36(6), 819-823. Lippincott Williams & Wilkins
Den Boer, E, Koch, B C, Huisman, R & De Jonge, R 2014, ' Using fluorescence polarization immunoassay for determination of erythrocyte methotrexate polyglutamates, a quick and easy test? ', Therapeutic Drug Monitoring, vol. 36, no. 6, pp. 819-823 . https://doi.org/10.1097/FTD.0000000000000085
BACKGROUND:: The folate antagonist methotrexate (MTX) is the anchor drug in the treatment of rheumatoid arthritis. The therapeutic effects of MTX are attributed to the intracellular levels of MTX, present in the cell as polyglutamates (MTX-PGs). We a
Autor:
Ethan den Boer, Saskia M F Pluijm, Maurits C F J de Rotte, Behiye Özcan, Pascal H P de Jong, Johanna M. W. Hazes, Robert de Jonge, Angelique E. A. M. Weel, Jan Lindemans
Publikováno v:
Arthritis & Rheumatology. 66:2026-2036
Objective To investigate whether methotrexate (MTX) use, as compared to other therapies, and erythrocyte methotrexate polyglutamate (MTXGlu) concentrations are associated with changes in glycosylated hemoglobin (HbA1c) levels in rheumatoid arthritis
Publikováno v:
Autoimmunity Reviews, 15(11), 1109-1110. Elsevier
Wassenaar, S, den Boer, E, Westerman, E M, Hazes, J M & de Jonge, R 2016, ' Letter to the editor in response to the article "Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients" by Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H, Autoimmun Rev. 2014 Nov.;13(11):1109-13 Height of MTX-PG levels in low-dose MTX-toxicity differs according to the time of onset ', Autoimmunity Reviews, vol. 15, no. 11, pp. 1109-1110 . https://doi.org/10.1016/j.autrev.2016.04.006
Wassenaar, S, den Boer, E, Westerman, E M, Hazes, J M & de Jonge, R 2016, ' Letter to the editor in response to the article "Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients" by Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H, Autoimmun Rev. 2014 Nov.;13(11):1109-13 Height of MTX-PG levels in low-dose MTX-toxicity differs according to the time of onset ', Autoimmunity Reviews, vol. 15, no. 11, pp. 1109-1110 . https://doi.org/10.1016/j.autrev.2016.04.006
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::997d1aef2ac2b98ec6e38299d1f961b5
https://research.vumc.nl/en/publications/d5c9ec15-c215-47ad-8754-3a69ae6dbff6
https://research.vumc.nl/en/publications/d5c9ec15-c215-47ad-8754-3a69ae6dbff6
Autor:
Robert de Jonge, Theo M. Luider, Ethan den Boer, Mariël L. te Winkel, Birgit C. P. Koch, Roland J. W. Meesters, Sandra G. Heil, Bertrand D. van Zelst, Marry M. van den Heuvel-Eibrink
Publikováno v:
Therapeutic Drug Monitoring, 34(4), 432-439. Lippincott Williams & Wilkins
Introduction: High-dose methotrexate (MTX) is used in the treatment of proliferative diseases such as acute lymphoblastic leukemia. Therapeutic drug monitoring of plasma MTX is important to monitor efficacy and adverse events. The authors aimed to de
Autor:
Theo M. Luider, Robert de Jonge, Rob J. van Klaveren, Ethan den Boer, Jan Lindemans, Roland J. W. Meesters, Robin Cornelissen
Publikováno v:
Analytical and Bioanalytical Chemistry, 398(7-8), 2943-2948. Springer-Verlag
Analytical and Bioanalytical Chemistry
Analytical and Bioanalytical Chemistry
An analytical assay has been developed and validated for ultrafast and high-throughput mass spectrometric determination of pemetrexed concentrations in plasma using matrix assisted laser desorption/ionization-triple quadrupole-tandem mass spectrometr
Autor:
Maurits C J F de Rotte, Robert de Jonge, Saskia M F Pluijm, Ethan den Boer, Sandra G. Heil, Johanna M. W. Hazes
Publikováno v:
Journal of Rheumatology, 41(11), 2167-2178. Journal of Rheumatology
Objective.Low-dose methotrexate (MTX) is the anchor drug in the treatment for rheumatoid arthritis (RA). Response to MTX is related to the intracellular MTX-polyglutamate (MTX-PG) levels and little is known about its determinants. We aimed to define
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b00795c38c7e724b7fc1538de63dbf9f
https://pure.eur.nl/en/publications/9341a49e-3988-4c97-8880-cc14e219b5fe
https://pure.eur.nl/en/publications/9341a49e-3988-4c97-8880-cc14e219b5fe
Autor:
Ethan den Boer, Maja Bulatović Ćalasan, Robert de Jonge, Sebastiaan J. Vastert, Nico M Wulffraat, Maurits C F J de Rotte, Sylvia Kamphuis
Publikováno v:
Annals of the Rheumatic Diseases, 74(2), 402-407. BMJ Publishing Group
Ćalasan, M B, Den Boer, E, De Rotte, M C F J, Vastert, S J, Kamphuis, S, De Jonge, R & Wulffraat, N M 2015, ' Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients ', Annals of the Rheumatic Diseases, vol. 74, no. 2, pp. 402-407 . https://doi.org/10.1136/annrheumdis-2013-203723
Ćalasan, M B, Den Boer, E, De Rotte, M C F J, Vastert, S J, Kamphuis, S, De Jonge, R & Wulffraat, N M 2015, ' Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients ', Annals of the Rheumatic Diseases, vol. 74, no. 2, pp. 402-407 . https://doi.org/10.1136/annrheumdis-2013-203723
Objective: To determine association of erythrocyte methotrexate polyglutamates (MTX-PG) with disease activity and adverse effects in a prospective juvenile idiopathic arthritis (JIA) cohort. Methods: One hundred and thirteen JIA patients were followe
Autor:
Maurits C F J, de Rotte, Pascal H P, de Jong, Ethan, den Boer, Saskia M F, Pluijm, Behiye, Özcan, Angelique E A M, Weel, Jan, Lindemans, Johanna M W, Hazes, Robert, de Jonge
Publikováno v:
Arthritisrheumatology (Hoboken, N.J.). 66(8)
To investigate whether methotrexate (MTX) use, as compared to other therapies, and erythrocyte methotrexate polyglutamate (MTXGlu) concentrations are associated with changes in glycosylated hemoglobin (HbA1c ) levels in rheumatoid arthritis (RA) pati
Publikováno v:
Rapid communications in mass spectrometry : RCM. 25(20)
A new ultrafast quantitative and high-throughput mass spectrometric method using matrix-assisted laser desorption/ionization triple quadrupole tandem mass spectrometry has been developed and validated for determination of intracellular erythrocyte co
Autor:
Rob J. van Klaveren, Robert de Jonge, Ron A. A. Mathôt, Ethan den Boer, Theo M. Luider, Roland J. W. Meesters, Jan Lindemans
Publikováno v:
Bioanalysis, 3(12), 1369-1378. Future Science
Background: A new analytical MS method using isotope dilution combined with MALDI-triple quadrupole MS/MS has been developed and validated for the determination of methotrexate and 7-hydroxymethotrexate in plasma. Methotrexate, methotrexate-d3, 7-hyd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76f6ae1a8f65dd2342deb70ed1cd0047
https://pure.amc.nl/en/publications/ultrafast-selective-quantification-of-methotrexate-in-human-plasma-by-highthroughput-maldiisotope-dilution-mass-spectrometry(fb9889d0-f446-46f9-b0e6-3f2ed5b0f754).html
https://pure.amc.nl/en/publications/ultrafast-selective-quantification-of-methotrexate-in-human-plasma-by-highthroughput-maldiisotope-dilution-mass-spectrometry(fb9889d0-f446-46f9-b0e6-3f2ed5b0f754).html